Drug intelligence / Profile preview

640EU

Development stage
Unknown
Lead developer
AIM Vaccine Co.
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

640EU is a vaccine product referenced as a "Class II vaccine" with a dosage of "1.0 ml" per available documentation. It is associated with the Chinese vaccine industry and appears to be produced by one of the major private sector vaccine companies in China, which has expanded through acquisitions and infrastructure upgrades to meet GMP standards. The specific antigen, disease target, or mechanism of action for 640EU is not detailed in the available sources; however, it is classified as a Class II vaccine under Chinese regulatory definitions, which typically includes vaccines for diseases such as influenza, hepatitis A/B/E, varicella, mumps, rubella, and others that are not part of China's national immunization program but are still important for public health[7].

Brand names
640EU
Other names
640EU

Beyond the preview

Go deeper on 640EU.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 640EU.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call